Parenteral Nutrition

5.0(1)
studied byStudied by 5 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/89

flashcard set

Earn XP

Description and Tags

Medicine

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

90 Terms

1
New cards

what is parenteral nutrition

form of nutritional support that is provided through intravenous administration

2
New cards

is parenteral nutrition specific to a disease state?

no - it is rather a method of provision of calories/energy used to prevent malnutrition

3
New cards

why is it important to recognize when and when not to use PN?

it is expensive and has risk of serious adverse events (appropriate use is essential)

4
New cards

appropriate use of PN includes:

recognizing when and when not to utilize based on clinical indications, develop a prescription that meets individual needs, monitor and adjust therapy as necessary, transition to enteral nutrition (EN) as soon as possible

5
New cards

what is the purpose of PN therapy

support physiologic energy needs when enteral nutrition cannot be provided safely/effectively, and provides macronutrients and micronutrients through intravenous route

6
New cards

complications of PN therapy:

hyperglycemia/hypoglycemia, electrolyte imbalances, hypertriglyceridemia, liver function abnormalities, pneumothorax, catheter occlusion, thrombus, phlebitis, and infections

7
New cards

what are the common electrolyte imbalances of PN?

hypokalemia, hypophosphatemia, hypomagnesemia (refeeding syndrome)

8
New cards

which labs indicated acute liver function abnormalities?

AST/ALT elevations

9
New cards

which labs indicated chronic liver function abnormalities?

alkaline phos/bilirubin > 2 weeks

10
New cards

T/F: central line associated infections and bacteremia are associated with EN

false

11
New cards

Advantages of Peripheral IV access (PIV) for PN administration:

bedside insertion into the veins of forearm/hand, and use for short-term duration

12
New cards

Disadvantages of Peripheral IV access (PIV) for PN administration:

increased risk of phlebitis, limited use based on osmolarity of the solution (max = 900 mOsm/L), and is not suitable for home PN/long-term use

13
New cards

Advantages of peripherally inserted central catheters (PICC) for PN administration:

bedside insertion into basilic, cephalic, or brachial veins with the tip in the superior vena cava, and is suitable for short-medium duration of PN

14
New cards

Disadvantages of peripherally inserted central catheters (PICC) for PN administration:

may require a radiologist guided placement, increased risk of DVT, and the site limits patient activity, easily removed, and easily infected

15
New cards

Advantages of Tunneled catheters (Ex: Broviac, Hickman) for PN administration:

suitable for long term PN, cuffed to minimize contamination/dislodgement, minimal restrictions to activity, and easier for self-care/hidden

16
New cards

Disadvantages of Tunneled catheters (Ex: Broviac, Hickman) for PN administration:

surgical/radiology guided insertion

17
New cards

what is a 3-in-1 product?

contains all three macronutrients within 1 bag

18
New cards

what is 3-in-1 synonymous with?

total nutritional admixture (TNA) or “all-in-one”

19
New cards

what are the concerns about 3-in-1 products?

compatibility and risk of cracking/”oiling” out

20
New cards

what patient population uses 3-in-1 products more commonly

adults - rarely used in peds

21
New cards

how do 3-in-1 products come prepared?

in premade bags with multiple chambers

22
New cards

what are 2-in-1 products?

contains only two of the macronutrients - dextrose and amino acids

23
New cards

T/F: if a patient is receiving a 2-in-1 product they will not receive any lipids during treatment

false

24
New cards

how are lipids given to patients receiving 2-in-1 products

they are infused as a separate product (co-infused)

25
New cards

which patient population primarily receives 2-in-1 products?

pediatric patients

26
New cards

what is a standard approach?

commercially available - premade PN bags with standardized concentrations

27
New cards

are standard approach premade PN bags used in pediatric patients?

NO

28
New cards

what is individualized approach?

compounded local/outsourced, prescription prepared based on individual patient needs

29
New cards

who typically receives individualized approach PN

NICU/Pediatric patients

30
New cards

what is “cycled” PN?

PN provided over a rate that is not the usual 24-hour period

31
New cards

when is cycled PN used?

used in long-term PN patients to allow for time “off” PN to minimize risk of IFALD

32
New cards

T/F: you should ramp-up and ramp-down the rate in cycled PN to avoid drastic shifts in glucose provided

true

33
New cards

what are the macronutrients in PN

protein (amino acids), carbohydrates (dextrose), and fats (lipids)

34
New cards

what are the micronutrients used in PN

electrolytes, vitamins, and trace elements

35
New cards

what is the kcal/gram of amino acids (protein)?

4

36
New cards

what is the usual osmolarity of amino acids in PN

10 mOsm per g/L or 100 mOsm/%

37
New cards

what types of amino acids are found in PN ?

essential and non-essential amino acids

38
New cards

T/F: amino acids products and concentrations utilized are age dependent

true

39
New cards

what is the kcal/gram of dextrose (carbohydrates)

3.4

40
New cards

what is the osmolarity of dextrose in PN

5 mOsm per g/L or 50 mOsm/%

41
New cards

what is the peripheral limit of dextrose

D10-12.5%

42
New cards

what product is used for PN dextrose?

D70W = 70% for compounding

43
New cards

what is the kcal/gram of fats

~9

44
New cards

what is the maximum rate of infusion for lipid emulsion (fat)

0.15g/kg/hour in pediatrics and 0.11g/kg/hour in adults

45
New cards

which lipid emulsion products are soybean oil based ILE?

Intralipid 20% and Nutrilipid 20% (20% = 2kcal/mL)

46
New cards

what is the goal dosing of Intralipid and Nutrilipid?

0.15g/kg/hour in pediatrics and 0.11g/kg/hour in adults

47
New cards

when is Intralipid and Nutrilipid used?

patients requiring PN as a source of EFA to prevent EFAD

48
New cards

which lipid products are combo products of soybean, MCT, olive, and fish oil-based

SMOF-lipid 20% (20% = 2kcal/mL)

49
New cards

goal dosing of SMOF-lipid 20%

neonates/infants - 3g/kg/day

children/adolescents - 2.5-3g/kg/day

50
New cards

when is SMOF-lipid 20% used?

patients requiring PN as a source of EFA to prevent EFAD

51
New cards

which lipid emulsion product is fish oil-based

Omegaven 10% (10% = 1.1 kcal/mL)

52
New cards

goal dosing of Omegaven 10%

neonates, infants, children, and adolescents - 1g/kg/day

53
New cards

when is Omegaven 10% used

in pediatric patients with PN-associated cholestasis

54
New cards

what must lipid emulsions be administered with?

must administer 1.2 micrometer (micron) filter

55
New cards

what is the maximum hang time for a single container of lipids?

12 hours (24-hour infusion = 2 “bags'“)

56
New cards

what is CI with lipid emulsions?

egg/soybean/fish allergies (dependent on product)

57
New cards

what things need to be monitored related to lipid emulsions

Intestinal failure associated liver disease (IFALD), hypertriglyceridemia, and essential fatty acid deficiency (EFAD)

58
New cards

what is hypertriglyceridemia in neonatal/pediatrics

> 200 mg/dL

59
New cards

what is hypertriglyceridemia in adults?

>400 mg/dL

60
New cards

what tests should be done to check for IFALD

liver function tests and bilirubin

61
New cards

who should be monitored for EFAD?

malnourished neonatal/pediatric patients or any patients utilizing lipid minimization strategies

62
New cards

how is potassium supplied in PN?

-chloride, -acetate, -phosphate

63
New cards

how is sodium supplied in PN

-chloride, -acetate, -phosphate

64
New cards

how is phosphate supplied in PN

potassium phosphate and sodium phosphate

65
New cards

what is calcium-phosphate precipitation

a concentration dependent reaction leading to in-solution precipitates to form

66
New cards

what are the factors that affect solubility of calcium-phosphate

dose of Ca/Phos in PN, pH of the final solution, temperature, time, and salt form (preference calcium gluconate)

67
New cards

T/F: when compounding, separate order of additives to minimize risk

true

68
New cards

should calcium or phosphate be added first to minimize calcium-phosphate precipitation?

phosphate

69
New cards

purpose of multivitamins:

essential for various organ system and physiological function (pediatrics need for neurodevelopment and growth)

70
New cards

which patients may require additional supplementation (multivitamins)

long-term PN and individualized

71
New cards

what are trace elements

included at standard dosing and commercial product utilized (zinc, copper, manganese, chromium, selenium)

72
New cards

what is anion balance

all positive cations provided must associate with negative anion (chloride, acetate)

73
New cards

T/F: chloride and acetate are intrinsic negative anions

true

74
New cards

how are orders usually prescribed for chloride and acetate

prescribed as ratios or min/maximum

75
New cards

what should be increased/decreased in metabolic acidosis

increase acetate, decreased chloride

76
New cards

what should be increased/decreased in metabolic alkalosis

decrease acetate, increase chloride

77
New cards

what is “creaming”?

compatibility of 3-in-1 solutions that is safe to use and is reversible with gentle agitation

78
New cards

what is “cracking”?

compatibility of 3-in-1 solutions that is unsafe to use and separation is irreversible

79
New cards

what is the minimum for stability in 3-in-1 solutions

AA 4%, Dextrose 10%, and ILE 2%

80
New cards

med examples that can be added to PN?

insulin, levocarnitine, heparin, famotidine (check compatibility, determine risk or clinical utility provided over 24-hours)

81
New cards

what safety checks should be performed when giving PNs

max lipid rate (0.15 g/kg/hour), glucose infusion rate (mg/kg/min), estimate osmolarity (AA + Dextrose), and check line/access (central vs. peripheral)

82
New cards

what monitoring should be done to determine efficacy of intervention?

weight, fluid balance, electrolytes + BUN/Cr, glucose, nitrogen balance, and long term (trace elements, vitamins, and EFA)

83
New cards

what monitoring should be done to determine toxicity of intervention?

refeeding syndrome, liver function tests/bilirubin, triglycerides, and infection (sign/symptoms)

84
New cards

what is the goal of nitrogen balance

achieve positive nitrogen balance which means the patient is in anabolic state (energy in > energy out)

85
New cards

how to determine how much nitrogen in?

Grams of protein / 6.25

86
New cards

how to determine how much nitrogen out?

UUN (g) - urine urea nitrogen (determined from a 12 to 24 hour urine collection)

87
New cards

what factor is used for insensible losses not captured within UUN?

+4

88
New cards

what is refeeding syndrome?

occurrence of electrolyte abnormalities in severely malnourished patients during rapid initiation of nutrition (enteral or parenteral)

89
New cards

what can refeeding syndrome lead to besides electrolyte depletion

fluid overload - monitor fluid status closely

90
New cards

which electrolytes needs to be monitored and aggressively supplemented in refeeding syndrome

potassium, phosphate, and magnesium